Advanced-stage tongue squamous cell carcinoma: a machine learning model for risk stratification and treatment planning




Alabi Rasheed Omobolaji, Elmusrati Mohammed, Leivo Ilmo, Almangush Alhadi, Mäkitie Antti A

PublisherTaylor & Francis

2023

Acta Oto-Laryngologica

ACTA OTO-LARYNGOLOGICA

ACTA OTO-LARYNGOL

143

3

206

214

9

0001-6489

1651-2251

DOIhttps://doi.org/10.1080/00016489.2023.2172208

https://www.tandfonline.com/doi/full/10.1080/00016489.2023.2172208

https://urn.fi/URN:NBN:fi-fe2023070790438



Background

A significant number of tongue squamous cell carcinoma (TSCC) patients are diagnosed at late stage.

Objectives

We primarily aimed to develop a machine learning (ML) model based on ensemble ML paradigm to stratify advanced-stage TSCC patients into the likelihood of overall survival (OS) for evidence-based treatment. We compared the survival outcome of patients who received either surgical treatment only (Sx) or surgery combined with postoperative radiotherapy (Sx + RT) or postoperative chemoradiotherapy (Sx + CRT).

Material and Methods

A total of 428 patients from Surveillance, Epidemiology, and End Results (SEER) database were reviewed. Kaplan-Meier and Cox proportional hazards models examine OS. In addition, a ML model was developed for OS likelihood stratification.

Results

Age, marital status, N stage, Sx, and Sx + CRT were considered significant. Patients with Sx + RT showed better OS than Sx + CRT or Sx alone. A similar result was obtained for T3N0 subgroup. For T3N1 subgroup, Sx + CRT appeared more favorable for 5-year OS. In T3N2 and T3N3 subgroups, the numbers of patients were small to make insightful conclusions. The OS predictive ML model showed an accuracy of 86.3% for OS likelihood prediction.

Conclusions and Significance

Patients stratified as having high likelihood of OS may be managed with Sx + RT. Further external validation studies are needed to confirm these results.



Last updated on 2025-27-06 at 15:50